QPPV.COM KNOWLEDGE ASSESSMENT

Knowledge Assessment: How PRAC Assesses a Safety Issue During an EMA Referral

Test your understanding of the concepts covered by How PRAC Assesses a Safety Issue During an EMA Referral.

Question 1 of 10Pass mark: 80%

Question 1 of 10 When spontaneous reports and an epidemiological study appear to conflict, what should PRAC do first?

Select the source supporting the more protective regulatory measure. Discard the spontaneous reports because epidemiology is always superior. Examine differences in populations, definitions, follow-up, bias, confounding, power and data quality that could explain the discrepancy. Average the results numerically without assessing methodological differences.

Question 2 of 10 Which statement correctly distinguishes a scientific conclusion from a regulatory recommendation?

They are identical because confirming a risk automatically specifies the regulatory measure. The scientific conclusion characterises what the evidence means, while the recommendation translates that conclusion into an action within the applicable legal framework. The regulatory recommendation is made before the evidence is interpreted. The scientific conclusion is limited to product-information wording.

Question 3 of 10 What is the proper role of an oral explanation by an MAH during an applicable referral procedure?

To substitute for a complete written evidence package. To negotiate the scientific conclusion directly with individual committee members. To clarify contested scientific issues and respond directly to concerns within the procedural framework, while maintaining evidentiary discipline. To present uncertainty as certainty in order to secure a favourable outcome.

Question 4 of 10 Which statement best describes the evidentiary approach expected in a PRAC referral assessment?

The strongest single data source should override all contradictory sources. The assessment should rely primarily on the source that initiated the referral. Relevant evidence from multiple sources should be integrated according to the question, with the strengths and limitations of each source considered. Only statistically significant epidemiological results should be used for regulatory reasoning.

Question 5 of 10 How should the marketing authorisation holder's submission be treated in the PRAC assessment?

It is the definitive interpretation because the MAH owns the relevant data. It is a separate commercial position that should not be integrated with regulatory evidence. It forms part of the evidence base and is evaluated alongside information from EMA, national authorities and other stakeholders. It may be considered only if it supports the rapporteur's preliminary conclusion.

Question 6 of 10 Which QPPV activity best demonstrates appropriate governance during a safety referral?

Ensuring that the referral response presents only the company's preferred interpretation. Reconstructing and documenting consistency between the referral submission, the safety database, prior signal assessments, aggregate reports and risk-management information. Treating the referral as separate from the established pharmacovigilance system. Assuming that a different PRAC conclusion automatically proves a historical system failure.

Question 7 of 10 Which internal statement most clearly separates evidence from interpretation and regulatory conclusion?

The cases prove the risk, so PRAC must restrict use. PRAC's wording is the evidence, and the MAH's view is the conclusion. The evidence shows a pattern; the MAH interprets its significance in a stated way; PRAC reaches its own scientific and regulatory conclusion. Because the MAH submitted the data, its interpretation is the regulatory conclusion.

Question 8 of 10 Which of the following is the best treatment of uncertainty in a scientific referral assessment?

Omit uncertainty from the conclusion to avoid weakening the regulatory recommendation. Treat uncertainty itself as evidence that the risk is large. Describe what is known, what can reasonably be inferred and what remains uncertain, including whether the uncertainty could affect the decision. Delay all regulatory action until every uncertainty has been resolved.

Question 9 of 10 What is the most appropriate interpretation of a PRAC request for additional data or clarification?

It necessarily proves that the MAH's original submission was deficient. It is part of the iterative scientific assessment and may address gaps, inconsistencies, subgroup questions or potential regulatory consequences. It means PRAC has already decided to restrict the product. It permits the MAH to replace the original evidence with unsupported opinion.

Question 10 of 10 What additional value can an epidemiological study provide compared with individual case reports?

It automatically establishes causality regardless of study quality. It can help assess relative occurrence in exposed and comparator populations, subject to design and bias limitations. It eliminates the need to examine clinical characteristics of individual cases. It provides a complete denominator in every circumstance.

Knowledge Assessment: How PRAC Assesses a Safety Issue During an EMA Referral

Cookie Settings